Aventis Inc.

Targets: 1
Filings: 2
Median premium: 144%
First filing: Feb 29, 2024
Latest filing: Apr 26, 2024

Targets

Company	Score before deal	Score now	Filings	Latest
Inhibrx, Inc.	—	—	2	Apr 26, 2024

Deal filings

Filed	Company	Form	Price	Premium
Apr 26, 2024	Inhibrx, Inc.	DEFM14A	$30.00	100%
Feb 29, 2024	Inhibrx, Inc.	PREM14A	$30.00	144.44%